FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

C Renner

Research Profile

Chemicals & Drugs

Disorders

Hodgkin's Disease

Living Beings

Physiology

Procedures

Anatomy

T-Lymphocytes

Co-author Network

Publications

TOP 3
S Bauer; C Renner; J P Juwana; G Held; S Ohnesorge; K Gerlach; Michael Pfreundschuh
Immunotherapy of human tumors with T-cell-activating bispecific antibodies: stimulation of cytotoxic pathways in vivo.
C Renner; L Trümper; JP Pfitzenmeier; U Loftin; K Gerlach; I Stehle; Andreas Wadle; Michael Pfreundschuh
Differential mRNA display at the single-cell level.
C Renner; G Held; S Ohnesorge; S Bauer; K Gerlach; JP Pfitzenmeier; Michael Pfreundschuh
Role of naive and memory T cells in tumor cell lysis mediated by bi-specific antibodies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of C Renner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

1999: S Bauer; C Renner; J P Juwana; G Held; S Ohnesorge; K Gerlach; Michael Pfreundschuh
Immunotherapy of human tumors with T-cell-activating bispecific antibodies: stimulation of cytotoxic pathways in vivo.
Cancer research 1999;59(8):1961-5.
1998: C Renner; L Trümper; JP Pfitzenmeier; U Loftin; K Gerlach; I Stehle; Andreas Wadle; Michael Pfreundschuh
Differential mRNA display at the single-cell level.
BioTechniques 1998;24(5):720-2, 724.
1997: C Renner; G Held; S Ohnesorge; S Bauer; K Gerlach; JP Pfitzenmeier; Michael Pfreundschuh
Role of naive and memory T cells in tumor cell lysis mediated by bi-specific antibodies.
Immunobiology 1997;197(1):122-32.
1997: C Renner; G Held; S Ohnesorge; S Bauer; K Gerlach; JP Pfitzenmeier; Michael Pfreundschuh
Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cells.
Cancer immunology, immunotherapy : CII 1997;44(2):70-6.
1996: C Renner; S Ohnesorge; G Held; S Bauer; W Jung; JP Pfitzenmeier; Michael Pfreundschuh
T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28.
Blood 1996;88(1):236-41.
1996: C Renner; S Bauer; Ugur Sahin; W Jung; R van Lier; G Jacobs; G Held; Michael Pfreundschuh
Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical model.
Blood 1996;87(7):2930-7.
1996: F Hartmann; C Renner; W Jung; Ugur Sahin; Michael Pfreundschuh
Treatment of Hodgkin's disease with bispecific antibodies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7 Suppl 4():143-6.
1996: Ugur Sahin; S Kraft-Bauer; S Ohnesorge; Michael Pfreundschuh; C Renner
Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors.
Cancer immunology, immunotherapy : CII 1996;42(1):9-14.
1995: C Renner; Michael Pfreundschuh
Treatment of heterotransplanted Hodgkin's tumors in SCID mice by a combination of human NK or T cells and bispecific antibodies.
Journal of hematotherapy 1995;4(5):447-51.
1995: C Renner; W Jung; Ugur Sahin; R van Lier; Michael Pfreundschuh
The role of lymphocyte subsets and adhesion molecules in T cell-dependent cytotoxicity mediated by CD3 and CD28 bispecific monoclonal antibodies.
European journal of immunology 1995;25(7):2027-33.
1994: W Jung; S Krueger; C Renner; Angela Gause; Ugur Sahin; L Trümper; Michael Pfreundschuh
Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources.
Molecular immunology 1994;31(17):1329-34.
1994: C Renner; W Jung; Ugur Sahin; R Denfeld; C Pohl; L Trümper; F Hartmann; Volker Diehl; R van Lier; Michael Pfreundschuh
Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells.
Science (New York, N.Y.) 1994;264(5160):833-5.
1994: I Schobert; C Renner; Michael Pfreundschuh; Volker Diehl; C Pohl
Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphoma.
Leukemia & lymphoma 1994;13(5-6):429-40.
1993: Andreas Hombach; W Jung; C Pohl; C Renner; Ugur Sahin; R Schmits; Jürgen Wolf; U Kapp; Volker Diehl; Michael Pfreundschuh
A CD16/CD30 bispecific monoclonal antibody induces lysis of Hodgkin's cells by unstimulated natural killer cells in vitro and in vivo.
International journal of cancer. Journal international du cancer 1993;55(5):830-6.
1993: C Renner; Michael Pfreundschuh; Volker Diehl; C Pohl
Active specific immunotherapy of Hodgkin's lymphoma by an anti-idiotype vaccine against the Hodgkin-associated CD30 antigen.
Annals of the New York Academy of Sciences 1993;690():352-4.
1993: C Pohl; R Denfeld; C Renner; W Jung; Heribert Bohlen; Ugur Sahin; Andreas Hombach; R van Lier; M Schwonzen; Volker Diehl
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
International journal of cancer. Journal international du cancer 1993;54(5):820-7.
1993: C Pohl; C Renner; M Schwonzen; I Schobert; V Liebenberg; W Jung; Jürgen Wolf; Michael Pfreundschuh; Volker Diehl
CD30-specific AB1-AB2-AB3 internal image antibody network: potential use as anti-idiotype vaccine against Hodgkin's lymphoma.
International journal of cancer. Journal international du cancer 1993;54(3):418-25.
1992: C Pohl; C Renner; M Schwonzen; M Sieber; P Lorenz; Michael Pfreundschuh; Volker Diehl
Anti-idiotype vaccine against Hodgkin's lymphoma: induction of B- and T-cell immunity across species barriers against CD30 antigen by murine monoclonal internal image antibodies.
International journal of cancer. Journal international du cancer 1992;50(6):958-67.